Market Research Logo

Neurovascular Devices Market Size By Product (Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy Devices, Embolic Protection Devices, Flow Diverters, Intrasaccular Devices, Liquid Embolic Coils, Balloon Catheters, Stent Retriev

Neurovascular Devices Market Size By Product (Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy Devices, Embolic Protection Devices, Flow Diverters, Intrasaccular Devices, Liquid Embolic Coils, Balloon Catheters, Stent Retrievers), By Process (Neurothrombectomy Procedure, Cerebral Angiography Technique, Stenting Technique, Coiling Procedure Technique, Flow Disruption Technique), By Therapeutic Application (Brain Aneurysm, Stenosis, Ischemic Strokes), By End-Use (Hospitals, Ambulatory Surgical Units, Clinics), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, France, UK, Italy, Spain, Russia, Turkey, Netherlands, Belgium, Austria, Switzerland, Poland, Czech Republic, Hungary, Portugal, Greece, Romania, Bulgaria, Denmark, Sweden, Norway, Finland, Japan, China, India, Australia, South Korea, Singapore, Hong Kong, Taiwan, Indonesia, Cambodia, Philippines, Vietnam, Malaysia, Thailand, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa), Application Potential, Competitive Market Share & Forecast, 2018 - 2024

Neurovascular Devices Market will reach USD 2.1 billion by 2024; as per a new research report.

Increasing prevalence and cost associated with neurological disorders such as brain aneurysm and acute ischemic stroke will be the major factor driving neurovascular devices industry growth over the forecast period. As per World Stroke Organization, worldwide 17 million people suffer from stroke each year. Also, stroke is one of the leading cause of death as well as long-term disability in the U.S., that will primarily drive the demand for neurovascular devices in the future.

Rising geriatric population vulnerable to brain disorders coupled with soaring demand for minimally invasive procedures will substantially influence neurovascular devices revenue size. Minimally invasive surgeries (MIS) cause lesser pain and blood loss that accounts for major factor in driving patient preference for MIS surgery. Thus, MIS neurovascular surgery should impel demand for neurovascular devices in forthcoming years.

Rising healthcare spending in emerging countries along with increasing government initiatives to prevent neurological disorders will foster market growth over the forecast timeframe. However, lack of neurosurgeons in the developing nations coupled with soaring cost of neurovascular devices are factors that can hinder market growth over the recent years.

Embolic coils product segment dominated the industry with revenue share of 31.3% in 2017. The segment will witness lucrative growth over the projected period due to its wide applications in therapeutic areas such as brain aneurysm and ischemic strokes.

Coiling procedure segment led the market with revenue of USD 607.0 in 2017 and is expected to witness positive trend over the forthcoming years. Rising number of patients suffering from brain aneurysm along with booming demand for minimally invasive procedures will augment segmental growth. Flow disruption technique is poised to be the fastest growing segment by 2024.

Ischemic strokes segment will dominate the market with revenue share of 43.2% in 2017 owing to its high incidence along with increasing cost burden on healthcare systems. Strong government support and rising funding for stoke prevention will foster segmental size in the foreseeable future. Stenosis will be fastest growing segment over the forecast period.

Hospitals end-use segment dominated the industry in 2017 and will register 3.8% CAGR by 2024. This is attributable to increasing neurological disorders and growing demand for neurovascular devices to treat patients suffering from neurovascular diseases.

Canada neurovascular devices industry will witness significant growth at 4.0% CAGR due to increasing incidences and mortality associated with stoke in the country. Presence of The Canadian Neurovascular Health Society emphasized on research of neurovascular conditions and creating awareness among patients will stimulate business growth.

Germany neurovascular devices market will drive Europe neurovascular devices market with share of 13.1% in 2017 as a result of growing prevalence of stroke in elderly patient base along with rising economic burden of neurovascular diseases in the country. This will augment demand for neurovascular devices in the future.

Some of the prominent market players operating in global neurovascular devices market are Terumo Corporation, Penumbra, Stryker, Johnson & Johnson (Depuy Synthes) and Medtronic. Major players are involved in collaborations and acquisitions to widen their product portfolio and expand company’s geographic presence.


Chapter 1. Methodology
1.1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
1.4.1. Secondary
1.4.1.1. Paid sources
1.4.1.2. Unpaid sources
1.4.2. Primary
Chapter 2. Executive Summary
2.1. Neurovascular devices industry 360º synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Process trends
2.1.4. Therapeutic application trends
2.1.5. End-use trends
2.1.6. Regional trends
Chapter 3. Neurovascular Devices Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2013 – 2024
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.1.1. Increasing number of brain aneurysm and ischemic strokes in U.S.
3.3.1.2. Rising demand for surgical procedures with minimum invasion
3.3.1.3. Advancement in process in developed regions
3.3.1.4. Government initiatives to modernize and expand healthcare infrastructure across the globe
3.3.2. Industry pitfalls & challenges
3.3.2.1. Need for designing more effective and low-cost treatments
3.3.2.2. Companies are facing challenges in commercialization across developing economies
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By process
3.4.3. By therapeutic application
3.4.4. By end-use
3.5. Regulatory and reimbursement landscape
3.5.1. U.S.
3.5.2. Europe
3.5.3. China
3.6. Pricing analysis
3.6.1. U.S.
3.6.2. Europe
3.6.3. China
3.6.4. Japan
3.7. Porter’s analysis
3.8. Company market share analysis, 2017
3.8.1. Strategy dashboard
3.9. Porter’s analysis
3.10. PESTEL analysis
Chapter 4. Neurovascular Devices Market, By Product
4.1. Key segment trends
4.2. Embolic coils
4.2.1. Market size, by region, 2013 – 2024 (USD Million)
4.2.2. Market size, by region, 2013 – 2024 (000’ Units)
Similar information is provided for
4.3. Carotid stents
4.4. Intracranial stents
4.5. Neurovascular thrombectomy devices
4.6. Embolic protection devices
4.7. Flow diverters
4.8. Intrasaccular devices
4.9. Liquid embolic coils
4.10. Balloon catheters
4.11. Stent retrievers
Chapter 5. Neurovascular Devices Market, By Process
5.1. Key segment trends
5.2. Neurothrombectomy procedure
5.2.1. Market size, by region, 2013 – 2024 (USD Million)
5.2.2. Market size, by region, 2013 – 2024 (000’ Units)
Similar information is provided for
5.3. Cerebral angiography technique
5.4. Stenting technique
5.5. Coiling procedure technique
5.6. Flow disruption technique
Chapter 6. Neurovascular Devices Market, By Therapeutic Application
6.1. Key segment trends
6.2. Brain aneurysm
6.2.1. Market size, by region, 2013 – 2024 (USD Million)
6.2.2. Market size, by region, 2013 – 2024 (000’ Units)
Similar information is provided for
6.3. Stenosis
6.4. Ischemic strokes
6.5. Others
Chapter 7. Neurovascular Devices Market, By End-Use
7.1. Key segment trends
7.2. Hospitals
7.2.1. Hospitals market by region, 2013-2024 (USD Million)
Similar information is provided for
7.3. Ambulatory surgical units
7.4. Clinics
Chapter 8. Neurovascular Devices Market, By Region
8.1. Key regional trends
8.2. North America
8.2.1. Market size, by country, 2013 – 2024 (USD Million)
8.2.2. Market size, by country, 2013 – 2024 (000’ Units)
8.2.3. Market size, by product, 2013 – 2024 (USD Million)
8.2.4. Market size, by product, 2013 – 2024 (000’ Units)
8.2.5. Market size, by process, 2013 – 2024 (USD Million)
8.2.6. Market size, by process, 2013 – 2024 (000’ Units)
8.2.7. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.2.8. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.2.9. Market size, by end-use, 2013 – 2024 (USD Million)
8.2.10. Market size, by end-use, 2013 – 2024 (000’ Units)
Similar information is provided for
8.2.11. U.S.
8.2.12. Canada
8.3. Europe
8.3.1. Market size, by country, 2013 – 2024 (USD Million)
8.3.2. Market size, by country, 2013 – 2024 (000’ Units)
8.3.3. Market size, by product, 2013 – 2024 (USD Million)
8.3.4. Market size, by product, 2013 – 2024 (000’ Units)
8.3.5. Market size, by process, 2013 – 2024 (USD Million)
8.3.6. Market size, by process, 2013 – 2024 (000’ Units)
8.3.7. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.3.8. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.3.9. Market size, by end-use, 2013 – 2024 (USD Million)
8.3.10. Market size, by end-use, 2013 – 2024 (000’ Units)
Similar information is provided for
8.3.11. Germany
8.3.12. France
8.3.13. UK
8.3.14. Italy
8.3.15. Spain
8.3.16. Russia
8.3.17. Turkey
8.3.18. Netherlands
8.3.19. Belgium
8.3.20. Austria
8.3.21. Switzerland
8.3.22. Poland
8.3.23. Czech Republic
8.3.24. Hungary
8.3.25. Portugal
8.3.26. Greece
8.3.27. Romania
8.3.28. Bulgaria
8.3.29. Denmark
8.3.30. Sweden
8.3.31. Norway
8.3.32. Finland
8.4. Asia Pacific
8.4.1. Market size, by country, 2013 – 2024 (USD Million)
8.4.2. Market size, by country, 2013 – 2024 (000’ Units)
8.4.3. Market size, by product, 2013 – 2024 (USD Million)
8.4.4. Market size, by product, 2013 – 2024 (000’ Units)
8.4.5. Market size, by process, 2013 – 2024 (USD Million)
8.4.6. Market size, by process, 2013 – 2024 (000’ Units)
8.4.7. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.8. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.9. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.10. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.11. Japan
8.4.11.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.11.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.11.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.11.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.11.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.11.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.11.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.11.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.12. China
8.4.12.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.12.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.12.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.12.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.12.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.12.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.12.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.12.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.13. India
8.4.13.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.13.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.13.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.13.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.13.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.13.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.13.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.13.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.14. Australia
8.4.14.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.14.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.14.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.14.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.14.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.14.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.14.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.14.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.15. South Korea
8.4.15.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.15.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.15.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.15.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.15.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.15.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.15.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.15.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.16. Singapore
8.4.16.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.16.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.16.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.16.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.16.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.16.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.16.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.16.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.17. Hong Kong
8.4.17.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.17.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.17.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.17.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.17.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.17.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.17.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.17.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.18. Taiwan
8.4.18.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.18.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.18.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.18.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.18.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.18.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.18.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.18.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.19. Indonesia
8.4.19.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.19.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.19.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.19.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.19.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.19.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.19.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.19.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.20. Cambodia
8.4.20.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.20.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.20.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.20.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.20.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.20.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.20.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.20.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.21. Philippines
8.4.21.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.21.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.21.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.21.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.21.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.21.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.21.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.21.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.22. Vietnam
8.4.22.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.22.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.22.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.22.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.22.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.22.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.22.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.22.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.23. Malaysia
8.4.23.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.23.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.23.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.23.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.23.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.23.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.23.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.23.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.4.24. Thailand
8.4.24.1. Market size, by product, 2013 – 2024 (USD Million)
8.4.24.2. Market size, by product, 2013 – 2024 (000’ Units)
8.4.24.3. Market size, by process, 2013 – 2024 (USD Million)
8.4.24.4. Market size, by process, 2013 – 2024 (000’ Units)
8.4.24.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.4.24.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.4.24.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.4.24.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.5. Latin America
8.5.1. Market size, by country, 2013 – 2024 (USD Million)
8.5.2. Market size, by country, 2013 – 2024 (000’ Units)
8.5.3. Market size, by product, 2013 – 2024 (USD Million)
8.5.4. Market size, by product, 2013 – 2024 (000’ Units)
8.5.5. Market size, by process, 2013 – 2024 (USD Million)
8.5.6. Market size, by process, 2013 – 2024 (000’ Units)
8.5.7. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.5.8. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.5.9. Market size, by end-use, 2013 – 2024 (USD Million)
8.5.10. Market size, by end-use, 2013 – 2024 (000’ Units)
8.5.11. Brazil
8.5.11.1. Market size, by product, 2013 – 2024 (USD Million)
8.5.11.2. Market size, by product, 2013 – 2024 (000’ Units)
8.5.11.3. Market size, by process, 2013 – 2024 (USD Million)
8.5.11.4. Market size, by process, 2013 – 2024 (000’ Units)
8.5.11.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.5.11.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.5.11.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.5.11.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.5.12. Mexico
8.5.12.1. Market size, by product, 2013 – 2024 (USD Million)
8.5.12.2. Market size, by product, 2013 – 2024 (000’ Units)
8.5.12.3. Market size, by process, 2013 – 2024 (USD Million)
8.5.12.4. Market size, by process, 2013 – 2024 (000’ Units)
8.5.12.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.5.12.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.5.12.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.5.12.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.5.13. Argentina
8.5.13.1. Market size, by product, 2013 – 2024 (USD Million)
8.5.13.2. Market size, by product, 2013 – 2024 (000’ Units)
8.5.13.3. Market size, by process, 2013 – 2024 (USD Million)
8.5.13.4. Market size, by process, 2013 – 2024 (000’ Units)
8.5.13.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.5.13.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.5.13.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.5.13.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.6. MEA
8.6.1. Market size, by country, 2013 – 2024 (USD Million)
8.6.2. Market size, by country, 2013 – 2024 (000’ Units)
8.6.3. Market size, by product, 2013 – 2024 (USD Million)
8.6.4. Market size, by product, 2013 – 2024 (000’ Units)
8.6.5. Market size, by process, 2013 – 2024 (USD Million)
8.6.6. Market size, by process, 2013 – 2024 (000’ Units)
8.6.7. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.6.8. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.6.9. Market size, by end-use, 2013 – 2024 (USD Million)
8.6.10. Market size, by end-use, 2013 – 2024 (000’ Units)
8.6.11. Saudi Arabia
8.6.11.1. Market size, by product, 2013 – 2024 (USD Million)
8.6.11.2. Market size, by product, 2013 – 2024 (000’ Units)
8.6.11.3. Market size, by process, 2013 – 2024 (USD Million)
8.6.11.4. Market size, by process, 2013 – 2024 (000’ Units)
8.6.11.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.6.11.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.6.11.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.6.11.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.6.12. UAE
8.6.12.1. Market size, by product, 2013 – 2024 (USD Million)
8.6.12.2. Market size, by product, 2013 – 2024 (000’ Units)
8.6.12.3. Market size, by process, 2013 – 2024 (USD Million)
8.6.12.4. Market size, by process, 2013 – 2024 (000’ Units)
8.6.12.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.6.12.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.6.12.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.6.12.8. Market size, by end-use, 2013 – 2024 (000’ Units)
8.6.13. South Africa
8.6.13.1. Market size, by product, 2013 – 2024 (USD Million)
8.6.13.2. Market size, by product, 2013 – 2024 (000’ Units)
8.6.13.3. Market size, by process, 2013 – 2024 (USD Million)
8.6.13.4. Market size, by process, 2013 – 2024 (000’ Units)
8.6.13.5. Market size, by therapeutic application, 2013 – 2024 (USD Million)
8.6.13.6. Market size, by therapeutic application, 2013 – 2024 (000’ Units)
8.6.13.7. Market size, by end-use, 2013 – 2024 (USD Million)
8.6.13.8. Market size, by end-use, 2013 – 2024 (000’ Units)
Chapter 9. Company Profiles
9.1. Amico JSC
9.1.1. Business overview
9.1.2. Financial data
9.1.3. Product landscape
9.1.4. SWOT analysis
9.2. Canon
9.2.1. Business overview
9.2.2. Financial data
9.2.3. Product landscape
9.2.4. Strategic outlook
9.2.5. SWOT analysis
9.3. Carestream healthcare
9.3.1. Business overview
9.3.2. Financial data
9.3.3. Product landscape
9.3.4. SWOT analysis
9.4. Fujifilm
9.4.1. Business overview
9.4.2. Financial data
9.4.3. Product landscape
9.4.4. Strategic outlook
9.4.5. SWOT analysis
9.5. GE Healthcare
9.5.1. Business overview
9.5.2. Financial data
9.5.3. Product landscape
9.5.4. Strategic outlook
9.5.5. SWOT analysis
9.6. Hologic
9.6.1. Business overview
9.6.2. Financial data
9.6.3. Product landscape
9.6.4. Strategic outlook
9.6.5. SWOT analysis
9.7. I.M.S.
9.7.1. Business overview
9.7.2. Financial data
9.7.3. Product landscape
9.7.4. Strategic outlook
9.7.5. SWOT analysis
9.8. Konica Minolta
9.8.1. Business overview
9.8.2. Financial data
9.8.3. Product landscape
9.8.4. Strategic outlook
9.8.5. SWOT analysis
9.9. Korean C
9.9.1. Business overview
9.9.2. Financial data
9.9.3. Product landscape
9.9.4. SWOT analysis
9.10. Medical technologies
9.10.1. Business overview
9.10.2. Product landscape
9.10.3. SWOT analysis
9.11. Planmed Oy
9.11.1. Business overview
9.11.2. Financial data
9.11.3. Product landscape
9.11.4. SWOT analysis
9.12. Philips
9.12.1. Business overview
9.12.2. Financial data
9.12.3. Product landscape
9.12.4. Strategic outlook
9.12.5. SWOT analysis
9.13. Siemens Healthcare
9.13.1. Business overview
9.13.2. Financial data
9.13.3. Product landscape
9.13.4. Strategic outlook
9.13.5. SWOT analysis
Data Tables
TABLE 1. Neurovascular devices industry 360 0 synopsis, 2013 – 2024
TABLE 2. Global neurovascular devices market, 2013 - 2024 (USD Billion)
TABLE 3. Global neurovascular devices market, 2013 - 2024 (000’ Units)
TABLE 4. Global neurovascular devices market, by product, 2013 - 2024 (USD Million)
TABLE 5. Global neurovascular devices market, by product, 2013 - 2024 (000’ Units)
TABLE 6. Global neurovascular devices market, by process, 2013 - 2024 (USD Million)
TABLE 7. Global neurovascular devices market, by process, 2013 - 2024 (000’ Units)
TABLE 8. Global neurovascular devices market, by therapeutic application, 2013 - 2024 (USD Million)
TABLE 9. Global neurovascular devices market, by therapeutic application, 2013 - 2024 (000’ Units)
TABLE 10. Global neurovascular devices market, by end-use, 2013 - 2024 (USD Million)
TABLE 11. Global neurovascular devices market, by end-use, 2013 - 2024 (000’ Units)
TABLE 12. Global neurovascular devices market, by region, 2013 - 2024 (USD Million)
TABLE 13. Global neurovascular devices market, by region, 2013 - 2024 (000’ Units)
TABLE 14. Industry impact forces
TABLE 15. Health associated risks caused by neurovascular mechanical thrombectomy device and mitigation measures identified by U.S. FDA
TABLE 16. Reimbursement for aneurysms for hospital inpatient services in the U.S.
TABLE 17. Reimbursement for mechanical thrombectomy devices in Europe
TABLE 18. Embolic coils market, by region, 2013 – 2024 (USD Million)
TABLE 19. Embolic coils market, by region, 2013 – 2024 (000’ Units)
TABLE 20. Carotid stents market, by region, 2013 – 2024 (USD Million)
TABLE 21. Carotid stents market, by region, 2013 – 2024 (000’ Units)
TABLE 22. Intracranial stents market, by region, 2013 – 2024 (USD Million)
TABLE 23. Intracranial stents market, by region, 2013 – 2024 (000’ Units)
TABLE 24. Neurovascular thrombectomy devices market, by region, 2013 – 2024 (USD Million)
TABLE 25. Neurovascular thrombectomy devices market, by region, 2013 – 2024 (000’ Units)
TABLE 26. Embolic protection devices market, by region, 2013 – 2024 (USD Million)
TABLE 27. Embolic protection devices market, by region, 2013 – 2024 (000’ Units)
TABLE 28. Flow diverters market, by region, 2013 – 2024 (USD Million)
TABLE 29. Flow diverters market, by region, 2013 – 2024 (000’ Units)
TABLE 30. Intrasaccular devices market, by region, 2013 – 2024 (USD Million)
TABLE 31. Intrasaccular devices market, by region, 2013 – 2024 (000’ Units)
TABLE 32. Liquid embolic coils market, by region, 2013 – 2024 (USD Million)
TABLE 33. Liquid embolic coils market, by region, 2013 – 2024 (000’ Units)
TABLE 34. Balloon catheters market, by region, 2013 – 2024 (USD Million)
TABLE 35. Balloon catheters market, by region, 2013 – 2024 (000’ Units)
TABLE 36. Stent retrievers market, by region, 2013 – 2024 (USD Million)
TABLE 37. Stent retrievers market, by region, 2013 – 2024 (000’ Units)
TABLE 38. Neurothrombectomy procedure market, by region, 2013 – 2024 (USD Million)
TABLE 39. Neurothrombectomy market, by region, 2013 – 2024 (000’ Units)
TABLE 40. Cerebral angiography technique market, by region, 2013 – 2024 (USD Million)
TABLE 41. Cerebral angiography technique market, by region, 2013 – 2024 (000’ Units)
TABLE 42. Stenting technique market, by region, 2013 – 2024 (USD Million)
TABLE 43. Stenting technique market, by region, 2013 – 2024 (000’ Units)
TABLE 44. Coiling procedure technique market, by region, 2013 – 2024 (USD Million)
TABLE 45. Coiling procedure technique market, by region, 2013 – 2024 (000’ Units)
TABLE 46. Flow disruption technique market, by region, 2013 – 2024 (USD Million)
TABLE 47. Flow disruption technique market, by region, 2013 – 2024 (000’ Units)
TABLE 48. Brain aneurysm market, by region, 2013 – 2024 (USD Million)
TABLE 49. Brain aneurysm market, by region, 2013 – 2024 (000’ Units)
TABLE 50. Stenosis market, by region, 2013 – 2024 (USD Million)
TABLE 51. Stenosis market, by region, 2013 – 2024 (000’ Units)
TABLE 52. Ischemic strokes market, by region, 2013 – 2024 (USD Million)
TABLE 53. Ischemic strokes market, by region, 2013 – 2024 (000’ Units)
TABLE 54. Others market, by region, 2013 – 2024 (USD Million)
TABLE 55. Others market, by region, 2013 – 2024 (000’ Units)
TABLE 56. Hospitals market, by region, 2013 – 2024 (USD Million)
TABLE 57. Hospitals market, by region, 2013 – 2024 (000’ Units)
TABLE 58. Ambulatory surgical units market, by region, 2013 – 2024 (USD Million)
TABLE 59. Ambulatory surgical units market, by region, 2013 – 2024 (000’ Units)
TABLE 60. Clinics market, by region, 2013 – 2024 (USD Million)
TABLE 61. Clinics market, by region, 2013 – 2024 (000’ Units)
TABLE 62. North America neurovascular devices market, by country, 2013 – 2024 (USD Million)
TABLE 63. North America neurovascular devices market, by country, 2013 – 2024 (000’ Units)
TABLE 64. North America neurovascular devices market, by product, 2013 – 2024 (USD Million)
TABLE 65. North America neurovascular devices market, by product, 2013 – 2024 (000’ Units)
TABLE 66. North America neurovascular devices market, by process, 2013 – 2024 (USD Million)
TABLE 67. North America neurovascular devices market, by process, 2013 – 2024 (000’ Units)
TABLE 68. North America neurovascular devices market, by therapeutic application, 2013 – 2024 (USD Million)
TABLE 69. North America neurovascular devices market, by therapeutic application, 2013 – 2024 (000’ Units)
TABLE 70. North America neurovascular devices market, by end-use, 2013 – 2024 (USD Million)
TABLE 71. North America neurovascular devices market, by end-use, 2013 – 2024 (000’ Units)
TABLE 72. U.S. neurovascular devices market, by product, 2013 – 2024 (USD Million)
TABLE 73. U.S. neurovascular devices market, by product, 2013 – 2024 (000’ Units)
TABLE 74. U.S. neurovascular devices market, by process, 2013 – 2024 (USD Million)
TABLE 75. U.S. neurovascular devices market, by process, 2013 – 2024 (000’ Units)
TABLE 76. U.S. neurovascular devices market, by therapeutic application, 2013 – 2024 (USD Million)
TABLE 77. U.S. neurovascular devices market, by therapeutic application, 2013 – 2024 (000’ Units)
TABLE 78. U.S. neurovascular devices market, by end-use, 2013 – 2024 (USD Million)
TABLE 79. U.S. neurovascular devices market, by end-use, 2013 – 2024 (000’ Units)
TABLE 80. Canada neurovascular devices market, by product, 2013 – 2024 (USD Million)
TABLE 81. Canada neurovascular devices market, by product, 2013 – 2024 (000’ Units)
TABLE 82. Canada neurovascular devices market, by process, 2013 – 2024 (USD Million)
TABLE 83. Canada neurovascular devices market, by process, 2013 – 2024 (000’ Units)
TABLE 84. Canada neurovascular devices market, by therapeutic application, 2013 – 2024 (USD Million)
TABLE 85. Canada neurovascular devices market, by therapeutic application, 2013 – 2024 (000’ Units)
TABLE 86. Canada neurovascular devices market, by end-use, 2013 – 2024 (USD Million)
TABLE 87. Canada neurovascular devices market, by end-use, 2013 – 2024 (000’ Units)
TABLE 88. Europe neurovascular devices market, by country, 2013 – 2024 (USD Million)
TABLE 89. Europe neurovascular devices market, by country, 2013 – 2024 (000’ Units)
TABLE 90. Europe neurovascular devices market, by product, 2013 – 2024 (USD Million)
TABLE 91. Europe neurovascular devices market, by product, 2013 – 2024 (000’ Units)
TABLE 92. Europe neurovascular devices market, by process, 2013 – 2024 (USD Million)
TABLE 93. Europe neurovascular devices market, by process, 2013 – 2024 (000’ Units)
TABLE 94. Europe neurovascular devices market, by therapeutic application, 2013 – 2024 (USD Million)
TABLE 95. Europe neurovascular devices market, by therapeutic application, 2013 – 2024 (000’ Units)
TABLE 96. Europe neurovascular devices market, by end-use, 2013 – 2024 (USD Million)
TABLE 97. Europe neurovascular devices market, by end-use, 2013 – 2024 (000’ Units)
TABLE 98. Germany neurovascular devices market, by product, 2013 – 2024 (USD Million)
TABLE 99. Germany neurovascular devices market, by product, 2013 – 2024 (000’ Units)
TABLE 100. Germany neurovascular devices market, by process, 2013 – 2024 (USD Million)
TABLE 101. Germany neurovascular devices market, by process, 2013 – 2024 (000’ Units)
TABLE 102. Germany neurovascular devices market, by therapeutic application, 2013 – 2024 (USD Million)
TABLE 103. Germany neurovascular devices market, by therapeutic application, 2013 – 2024 (000’ Units)
TABLE 104. Germany neurovascular devices market, by end-use, 2013 – 2024 (USD Million)
TABLE 105. Germany neurovascular devices market, by end-use, 2013 – 2024 (000’ Units)
TABLE 106. France neurovascular devices market, by product, 2013 – 2024 (USD Million)
TABLE 107. France neurovascular devices market, by product, 2013 – 2024 (000’ Units)
TABLE 108. France neurovascular devices market, by process, 2013 – 2024 (USD Million)
TABLE 109. France neurovascular devices market, by process, 2013 – 2024 (000’ Units)
TABLE 110. France neurovascular devices market, by therapeutic application, 2013 – 2024 (USD Million)
TABLE 111. France neurovascular devices market, by therapeutic application, 2013 – 2024 (000’ Units)
TABLE 112. France neurovascular devices market, by end-use, 2013 – 2024 (USD Million)
TABLE 136. Spain neurovascular devices market, by end-use, 2013 – 2024 (USD M

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report